Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation after TAVR in Sievers Type-1 Bicuspid Aortic Valves.
Zito A, Buono A, Scotti A, Kim WK, Fabris T, de Biase C, Bellamoli M, Montarello N, Costa G, Alfadhel M, Koren O, Fezzi S, Bellini B, Massussi M, Bai L, Costa G, Mazzapicchi A, Giacomin E, Gorla R, Hug K, Briguori C, Bettari L, Messina A, Villa E, Boiago M, Romagnoli E, Orbach A, Laterra G, Aurigemma C, De Carlo M, Renker M, Gomez MG, Trani C, Ielasi A, Landes U, Rheude T, Testa L, Santos IA, Mangieri A, Saia F, Favero L, Chen M, Adamo M, Petronio AS, Montorfano M, Makkar RR, Mylotte D, Blackman DJ, Barbanti M, De Backer O, Tchètchè D, Tarantini G, Latib A, Maffeo D, Burzotta F. Zito A, et al. Among authors: bellamoli m. JACC Cardiovasc Interv. 2024 May 7:S1936-8798(24)00740-4. doi: 10.1016/j.jcin.2024.05.002. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 38749449 Free article.
Three-year clinical outcomes after transcatheter aortic valve implantation in patients with bicuspid aortic disease: Comparison between self-expanding and balloon-expandable valves.
Boiago M, Bellamoli M, De Biase C, Beneduce A, Alonso LG, Laforgia P, Feliachi S, Oliva OA, Dumonteil N, Tchétché D. Boiago M, et al. Among authors: bellamoli m. Catheter Cardiovasc Interv. 2024 May;103(6):1004-1014. doi: 10.1002/ccd.31041. Epub 2024 Apr 5. Catheter Cardiovasc Interv. 2024. PMID: 38577939
Coronary obstruction during TAVI procedure: When calcification distribution matters.
Paglianiti DA, Busco M, Bettari L, Bellamoli M, Campopiano E, Basile M, Maffeo D, Buono A. Paglianiti DA, et al. Among authors: bellamoli m. Cardiovasc Revasc Med. 2024 Apr 2:S1553-8389(24)00116-7. doi: 10.1016/j.carrev.2024.03.028. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38575448 No abstract available.
Contrast-zero TAVI with new-generation EVOLUT FX platform.
Busco M, Paglianiti DA, Bellamoli M, Bettari L, De Rosa ML, Messina A, Villa E, Maffeo D, Buono A. Busco M, et al. Among authors: bellamoli m. Cardiovasc Revasc Med. 2024 Jun;63:79-80. doi: 10.1016/j.carrev.2024.02.013. Epub 2024 Feb 20. Cardiovasc Revasc Med. 2024. PMID: 38402111 No abstract available.
Comparison of ultrasound- versus fluoroscopy-guidEd femorAl access In tranS-catheter aortic valve replacement In the Era of contempoRary devices: The EASIER registry.
Bianchini E, Morello A, Bellamoli M, Romagnoli E, Aurigemma C, Tagliaferri M, Montonati C, Dumonteil N, Cimmino M, Villa E, Corcione N, Bettari L, Messina A, Stanzione A, Troise G, Mor D, Maggi A, Bellosta R, Pegorer MA, Zoccai GB, Ielasi A, Burzotta F, Trani C, Maffeo D, Tchétché D, Buono A, Giordano A. Bianchini E, et al. Among authors: bellamoli m. Cardiovasc Revasc Med. 2024 May;62:40-47. doi: 10.1016/j.carrev.2023.12.007. Epub 2023 Dec 16. Cardiovasc Revasc Med. 2024. PMID: 38135568
A randomized control trial to assess optical coherence tomography parameters of the Xlimus drug-eluting stent: the XLIMIT trial.
Testa L, Squillace M, Ventrella N, Moreno R, Jiménez-Valero S, Serra A, Gomez Hospital JA, Bellamoli M, Popolo Rubbio A, Bedogni F. Testa L, et al. Among authors: bellamoli m. Front Cardiovasc Med. 2023 Sep 6;10:1199475. doi: 10.3389/fcvm.2023.1199475. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745092 Free PMC article.
Radial artery occlusion after transradial procedures: impact on 1-year adverse events.
Pacchioni A, Pesarini G, Sanz-Sanchez J, Sgueglia GA, Bellamoli M, Ferro J, Mugnolo A, Morandin R, Penzo C, Turri R, Guiducci V, Benfari G, Giovannini D, Saccà S, Ribichini FL, Versaci F, Biondi-Zoccai G, Reimers B. Pacchioni A, et al. Among authors: bellamoli m. Minerva Cardiol Angiol. 2023 Aug;71(4):414-420. doi: 10.23736/S2724-5683.22.06112-9. Epub 2022 Dec 5. Minerva Cardiol Angiol. 2023. PMID: 36468762
Radial artery occlusion after conventional and distal radial access: Impact of preserved flow and time-to-hemostasis in a propensity-score matching analysis of 1163 patients.
Pacchioni A, Mugnolo A, Sanz Sanchez J, Sgueglia GA, Pesarini G, Bellamoli M, Saccà S, Ribichini F, Reimers B, Gasparini GL. Pacchioni A, et al. Among authors: bellamoli m. Catheter Cardiovasc Interv. 2022 Feb;99(3):827-835. doi: 10.1002/ccd.30005. Epub 2021 Nov 16. Catheter Cardiovasc Interv. 2022. PMID: 34783423
21 results